Top Markets
Coin of the day
Marizyme, Inc. Marizyme, Inc.

Marizyme, Inc.

MRZM
Rang in Aktien #41141
Marizyme, Inc. is a life sciences company primarily engaged in bringing... Marizyme, Inc. is a life sciences company primarily engaged in bringing innovative medical technologies from development to market. Its offerings include DuraGraft, a unique single-application treatment administered during vascular and bypass surgeries, engineered to maintain the function and structure of the endothelium, along with other critical characteristics. The company is also progressing with various therapeutic products utilizing its Krillase protease-based platform. These are being developed to address conditions such as severe wounds and burns, acute ischemic stroke, deep vein thrombosis, and for the removal of dental plaque and biofilms. Additionally, Marizyme focuses on creating solutions to mitigate the damaging effects of ischemia-reperfusion injury in different grafting and organ transplantation procedures, among other medical applications. A further key initiative is the development of MATLOC, a digital, point-of-care, lab-on-chip device platform designed for the screening and diagnosis of chronic kidney disease. Established in 2007, Marizyme, Inc., previously known as GBS Enterprises Incorporated, is headquartered in Jupiter, Florida.
Aktienkurs
$0.0003
Zuletzt synchronisiert: 2026-08-11
Marktkapitalisierung
$39.54K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Marizyme, Inc. (MRZM)

Kategorie

Kursverlauf für Marizyme, Inc. (MRZM)
Höchster Schlusskurs: $0.00 am 2026-08-01

Niedrigster Schlusskurs: $1.01 am 2010-11-01
Kursverlauf der Aktie von Marizyme, Inc. von 2010 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 0.00%
2025 -98.90%
2024 -78.19%
2023 -86.16%
2022 -43.23%
2021 -36.30%
2020 294.78%
2019 -52.41%
2018 6,568.42%
2017 -53.33%
2016 -45.18%
2015 -50.00%
2014 13.62%
2013 -40.42%
2012 -88.61%
2011 58.26%
2010 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$527.87 33.33%
US
$873.57 35.10%
NL
$745.48 9.02%
CH
$1.08K -6.68%
KR
$260.24 16.81%
BE